✦ LIBER ✦
Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months
✍ Scribed by Ramadhani A Noor, Michael Thiesen, Benjamin Mordmuller, Paul Milligan…
- Book ID
- 120686505
- Publisher
- BioMed Central
- Year
- 2010
- Tongue
- English
- Weight
- 175 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1475-2875
No coin nor oath required. For personal study only.